Retraction Watch

No delight for Turkish surgeon in authorship dispute over case study

A surgeon in Turkey has won a court case in which he argued that he deserved to be named in a list of authors from his institution who’d published a paper. But even that doesn’t appear to have satisfied the aggrieved medic, as you’ll see.

The article, “Late onset traumatic diaphragmatic herniation leading to intestinal obstruction and pancreatitis: two separate cases,” was written by a group from the Department of General Surgery at Ankara Numune Training and Research Hospital. The list of authors comprised Tolga Dinc, Selami Ilgaz Kayilioglu and Faruk Coskun … but not Baris Yildiz, a colleague in the department.

The paper appeared in Case Reports in Emergency Medicine, a Hindawi title, which has issued a rather byzantine expression of concern about the article:

Blood pulls deceased star oncologist’s paper after Stanford inquiry

Blood has retracted a 2011 article by a now-deceased Stanford researcher, Holbrook Kohrt, who earlier this month lost two other papers over concerns about the whereabouts of the data.

The journal’s move comes about a week after Retraction Watch posted a story on the previous retractions, in the Journal of Clinical Investigation (JCI), of Kohrt’s work. As we noted then, Kohrt was a superstar young faculty member who died in 2016 of complications of hemophilia. He was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.

The Blood paper was titled “CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.” The paper has been cited 148 times, according to Clarivate Analytics’ Web of Science.

Weekend reads: Researcher resigns following questions about ties to China; grad student’s suicide sparks misconduct investigation; study of chronic fatigue syndrome corrected

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured retractions and expressions of concern for a prominent cancer researcher; retractions for a deceased star researcher at Stanford; and a new director for a U.S. government watchdog. Here’s what was happening elsewhere:

Forensics Friday: Notice anything odd about this image?

Ever wanted to hone your skills as a scientific sleuth? Now’s your chance.

Thanks to the American Society for Biochemistry and Molecular Biology (ASBMB), which is committed to educating authors on best practices in publishing, figure preparation, and reproducibility, we’re presenting the eighth in a series, Forensics Friday.

Take a look at the image below, and then take our poll. After that, click on the link below to find out the right answer.

US government watchdog gets new director

The U.S. Office of Research Integrity (ORI) has a new director.

Elisabeth (Lis) Handley, currently deputy operations director of the Center for Medicaid and Medicare Services (CMS) Center for Program Integrity, will become interim director of the ORI on August 26. (CMS and ORI are both part of the Department of Health and Human Services (HHS)). Wanda Jones, formerly interim director and now deputy director, will remain at the agency in her current role.

Handley, according to an announcement sent to HHS employees,

Cancer specialists in Mexico earn third retraction following questions about their data

Cases of cancers seen at the Instituto Mexicano del Seguro Social, according to researcher Agustin Avilés

A group of cancer researchers in Mexico has lost their third paper over concerns about the integrity of their data.

Neither the new retraction, in the journal Hematology, nor the previous two, cite misconduct as the reason for the removals. However, the statements do refer to lack of reliability of results, “ambiguities and inconsistencies” in the findings and other serious issues.

The first author on each paper is Agustin Avilés, whom the Hematology article listed as being with the National Medical Center in Mexico City.

According to the retraction notice:

Chemistry researcher who studies oil wells is up to seven retractions

A chemistry researcher in India is up to seven retractions and one correction for problematic images and other issues.

The researcher, Mahendra Yadav, was the first author on an article titled “Corrosion inhibition of tubing steel during acidization of oil and gas wells,” which appeared in 2013 in the Journal of Petroleum Engineering (JPE). Yadav, who also has a correction for similar concerns, and who has a fairly extensive entry in PubPeer, is listed as being affiliated with the Department of Applied Chemistry at the Indian School of Mines, in Dhanbad.

According to the notice:

Stanford calling for retractions of work by deceased star cancer researcher

The Journal of Clinical Investigation has retracted two papers from the lab of one of Stanford University’s most prominent cancer researchers over concerns about the integrity of the data.

The articles, published in 2012 and 2014, described work on ways of priming the immune system to enhance the activity of drugs to fight cancer.

The first author on the two articles was Holbrook “Brook” Kohrt, a superstar young faculty member who died in 2016 of complications of hemophilia. Kohrt was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.

Georgia State researcher has two papers retracted, eight flagged. He’s not happy about it.

The Journal of Biological Chemistry has retracted two papers by a Georgia State University researcher, as well as flagged eight more with expressions of concern, a move the scientist called “unfair and unjustified.”

Ming-Hui Zou, the common author on all ten papers — as well as on two more that have been corrected by the same journal — is, according to Georgia State,

an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University…

Zou was at the University of Oklahoma when the papers in question were published. He moved to Georgia State in 2015.

Here’s the retraction notice for “Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo,” published in 2008 Zou as the last author:

Weekend reads: Questions swirl over kidney transplant papers from China; author apologizes for paper of whether women performed medical procedures as well as men; reports detail widespread fraud in UK lab

Retraction Watch came back online on Wednesday of this week, after a 10-day outage for technical issues that may have involved a DDOS attack. That meant there was no Weekend Reads for two weeks, so to catch up, we posted one yesterday, and are posting another today. Here’s what’s been happening elsewhere:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: